Both NIK and TRAF6 interact directly with some receptors through an intermediate protein, leading to the activation of the immune response [25], such as dendritic cells (DCs) and naïve T cells [25], and supporting the tumor progression [26]. Here, TRAF6 is linked to neoplasm.